| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Cancer Research Campaign Laboratories,*
the
Beatson Institute for Cancer Research, Bearsden, Glasgow, Scotland; the
Academic Transfusion Medicine Unit,§
Department
of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow,
Scotland; the Department of Pathology,¶
University
of Glasgow, Glasgow, Scotland; the Departments of
Dermatology
and
Pathology,||
University of Vienna, Vienna, Austria;
Novartis Forschunginstitut,**
Vienna, Austria;
and Leukosite Incorporated,
Cambridge, Massachusetts
The lymphatic vessels (lymphatics) play an important role in
channeling fluid and leukocytes from the tissues to the secondary
lymphoid organs. In addition to driving leukocyte egress from
blood, chemokines have been suggested to contribute to
leukocyte recirculation via the lymphatics. Previously, we have
demonstrated that binding sites for several pro-inflammatory
ß-chemokines are found on the endothelial cells (ECs) of lymphatics
in human dermis. Here, using the MIP-1
isoform
MIP-1P, we have extended these studies to further support
the contention that the in situ chemokine binding to
afferent lymphatics exhibits specificity akin to that observed
in vitro with the promiscuous ß-chemokine receptor D6.
We have generated monoclonal antibodies to human D6 and showed D6
immunoreactivity on the ECs lining afferent lymphatics,
confirmed as such by staining serial skin sections with antibodies
against podoplanin, a known lymphatic EC marker. In
parallel, in situ hybridization on skin with
antisense D6 probes demonstrated the expression of D6 mRNA by lymphatic
ECs. D6-immunoreactive lymphatics were also abundant in mucosa and
submucosa of small and large intestine and appendix, but not
observed in several other organs tested. In lymph nodes, D6
immunoreactivity was present on the afferent lymphatics and also in
subcapsular and medullary sinuses. Tonsilar lymphatic sinuses were also
D6-positive. Peripheral blood cells and the ECs of blood vessels and
high endothelial venules were consistently nonreactive with anti-D6
antibodies. Additionally, we have demonstrated that D6
immunoreactivity is detectable in some malignant vascular tumors
suggesting they may be derived from, or phenotypically similar
to, lymphatic ECs. This is the first demonstration of chemokine
receptor expression by lymphatic ECs, and suggests that D6 may
influence the chemokine-driven recirculation of leukocytes through the
lymphatics and modify the putative chemokine effects on the development
and growth of vascular tumors.
This article has been cited by other articles:
 |
|
 |
|
  R. Bonecchi, E. M. Borroni, A. Anselmo, A. Doni, B. Savino, M. Mirolo, M. Fabbri, V. R. Jala, B. Haribabu, A. Mantovani, et al. Regulation of D6 chemokine scavenging activity by ligand- and Rab11-dependent surface up-regulation Blood, August 1, 2008; 112(3): 493 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Cardona, M. E. Sasse, L. Liu, S. M. Cardona, M. Mizutani, C. Savarin, T. Hu, and R. M. Ransohoff Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues Blood, July 15, 2008; 112(2): 256 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. BALUK and D. M. MCDONALD Markers for Microscopic Imaging of Lymphangiogenesis and Angiogenesis Ann. N.Y. Acad. Sci., May 1, 2008; 1131(1): 1 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. HITCHCOCK and L. NIKLASON Lymphatic Tissue Engineering: Progress and Prospects Ann. N.Y. Acad. Sci., May 1, 2008; 1131(1): 44 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. JOHNSON and D. G. JACKSON Cell Traffic and the Lymphatic Endothelium Ann. N.Y. Acad. Sci., May 1, 2008; 1131(1): 119 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. DAS and M. SKOBE Lymphatic Vessel Activation in Cancer Ann. N.Y. Acad. Sci., May 1, 2008; 1131(1): 235 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Trujillo, E. C. O'Connor, S. L. Kunkel, and C. M. Hogaboam A Novel Mechanism for CCR4 in the Regulation of Macrophage Activation in Bleomycin-Induced Pulmonary Fibrosis Am. J. Pathol., May 1, 2008; 172(5): 1209 - 1221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. V. McCulloch, V. Morrow, S. Milasta, I. Comerford, G. Milligan, G. J. Graham, N. W. Isaacs, and R. J. B. Nibbs Multiple Roles for the C-terminal Tail of the Chemokine Scavenger D6 J. Biol. Chem., March 21, 2008; 283(12): 7972 - 7982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Manzo, S. Bugatti, R. Caporali, R. Prevo, D. G. Jackson, M. Uguccioni, C. D. Buckley, C. Montecucco, and C. Pitzalis CCL21 Expression Pattern of Human Secondary Lymphoid Organ Stroma Is Conserved in Inflammatory Lesions with Lymphoid Neogenesis Am. J. Pathol., November 1, 2007; 171(5): 1549 - 1562. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hansell and R. Nibbs Professional and Part-Time Chemokine Decoys in the Resolution of Inflammation Sci. Signal., May 1, 2007; 2007(384): pe18 - pe18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Martinez de la Torre, C. Buracchi, E. M. Borroni, J. Dupor, R. Bonecchi, M. Nebuloni, F. Pasqualini, A. Doni, E. Lauri, C. Agostinis, et al. Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6 PNAS, February 13, 2007; 104(7): 2319 - 2324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Whitehead, T. Wang, L. M. DeGraff, J. W. Card, S. A. Lira, G. J. Graham, and D. N. Cook The Chemokine Receptor D6 Has Opposing Effects on Allergic Inflammation and Airway Reactivity Am. J. Respir. Crit. Care Med., February 1, 2007; 175(3): 243 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Meddows-Taylor, S. L. Donninger, M. Paximadis, D. B. Schramm, F. S. Anthony, G. E. Gray, L. Kuhn, and C. T. Tiemessen Reduced ability of newborns to produce CCL3 is associated with increased susceptibility to perinatal human immunodeficiency virus 1 transmission J. Gen. Virol., July 1, 2006; 87(7): 2055 - 2065. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sfriso, F. Oliviero, F. Calabrese, M. Miorin, M. Facco, A. Contri, A. Cabrelle, I. Baesso, F. Cozzi, M. Andretta, et al. Epithelial CXCR3-B Regulates Chemokines Bioavailability in Normal, but Not in Sjogren's Syndrome, Salivary Glands J. Immunol., February 15, 2006; 176(4): 2581 - 2589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. D. Neil, M. M. I. Aasa-Chapman, P. R. Clapham, R. J. Nibbs, A. McKnight, and R. A. Weiss The Promiscuous CC Chemokine Receptor D6 Is a Functional Coreceptor for Primary Isolates of Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2 on Astrocytes J. Virol., August 1, 2005; 79(15): 9618 - 9624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Bono, V.-M. Wasenius, P. Heikkila, J. Lundin, D. G. Jackson, and H. Joensuu High LYVE-1-Positive Lymphatic Vessel Numbers Are Associated with Poor Outcome in Breast Cancer Clin. Cancer Res., November 1, 2004; 10(21): 7144 - 7149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B Moser and K Willimann Chemokines: role in inflammation and immune surveillance Ann Rheum Dis, November 1, 2004; 63(suppl_2): ii84 - ii89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Galliera, V. R. Jala, J. O. Trent, R. Bonecchi, P. Signorelli, R. J. Lefkowitz, A. Mantovani, M. Locati, and B. Haribabu {beta}-Arrestin-dependent Constitutive Internalization of the Human Chemokine Decoy Receptor D6 J. Biol. Chem., June 11, 2004; 279(24): 25590 - 25597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Schaerli, L. Ebert, K. Willimann, A. Blaser, R. S. Roos, P. Loetscher, and B. Moser A Skin-selective Homing Mechanism for Human Immune Surveillance T Cells J. Exp. Med., May 3, 2004; 199(9): 1265 - 1275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mantovani, M. Locati, N. Polentarutti, A. Vecchi, and C. Garlanda Extracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll-like receptors: the new entry TIR8/SIGIRR J. Leukoc. Biol., May 1, 2004; 75(5): 738 - 742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Weber, E. Blair, C. V. Simpson, M. O'Hara, P. E. Blackburn, A. Rot, G. J. Graham, and R. J.B. Nibbs The Chemokine Receptor D6 Constitutively Traffics to and from the Cell Surface to Internalize and Degrade Chemokines Mol. Biol. Cell, May 1, 2004; 15(5): 2492 - 2508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bonecchi, M. Locati, E. Galliera, M. Vulcano, M. Sironi, A. M. Fra, M. Gobbi, A. Vecchi, S. Sozzani, B. Haribabu, et al. Differential Recognition and Scavenging of Native and Truncated Macrophage-Derived Chemokine (Macrophage-Derived Chemokine/CC Chemokine Ligand 22) by the D6 Decoy Receptor J. Immunol., April 15, 2004; 172(8): 4972 - 4976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Irjala, K. Alanen, R. Grenman, P. Heikkila, H. Joensuu, and S. Jalkanen Mannose Receptor (MR) and Common Lymphatic Endothelial and Vascular Endothelial Receptor (CLEVER)-1 Direct the Binding of Cancer Cells to the Lymph Vessel Endothelium Cancer Res., August 1, 2003; 63(15): 4671 - 4676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Matsui, K. Nagy-Bojarsky, P. Laakkonen, S. Krieger, K. Mechtler, S. Uchida, S. Geleff, D.-H. Kang, R. J. Johnson, and D. Kerjaschki Lymphatic Microvessels in the Rat Remnant Kidney Model of Renal Fibrosis: Aminopeptidase P and Podoplanin Are Discriminatory Markers for Endothelial Cells of Blood and Lymphatic Vessels J. Am. Soc. Nephrol., August 1, 2003; 14(8): 1981 - 1989. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Fra, M. Locati, K. Otero, M. Sironi, P. Signorelli, M. L. Massardi, M. Gobbi, A. Vecchi, S. Sozzani, and A. Mantovani Cutting Edge: Scavenging of Inflammatory CC Chemokines by the Promiscuous Putatively Silent Chemokine Receptor D6 J. Immunol., March 1, 2003; 170(5): 2279 - 2282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. SAARISTO, M. J. KARKKAINEN, and K. ALITALO Insights into the Molecular Pathogenesis and Targeted Treatment of Lymphedema Ann. N.Y. Acad. Sci., December 1, 2002; 979(1): 94 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Clarijs, L. Schalkwijk, U. B. Hofmann, D. J. Ruiter, and R. M. W. de Waal Induction of Vascular Endothelial Growth Factor Receptor-3 Expression on Tumor Microvasculature as a New Progression Marker in Human Cutaneous Melanoma Cancer Res., December 1, 2002; 62(23): 7059 - 7065. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Jussila and K. Alitalo Vascular Growth Factors and Lymphangiogenesis Physiol Rev, July 1, 2002; 82(3): 673 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Irjala, E.-L. Johansson, R. Grenman, K. Alanen, M. Salmi, and S. Jalkanen Mannose Receptor Is a Novel Ligand for L-Selectin and Mediates Lymphocyte Binding to Lymphatic Endothelium J. Exp. Med., October 8, 2001; 194(8): 1033 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Karkkainen, A. Saaristo, L. Jussila, K. A. Karila, E. C. Lawrence, K. Pajusola, H. Bueler, A. Eichmann, R. Kauppinen, M. I. Kettunen, et al. A model for gene therapy of human hereditary lymphedema PNAS, October 5, 2001; (2001) 221449198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Karkkainen, A. Saaristo, L. Jussila, K. A. Karila, E. C. Lawrence, K. Pajusola, H. Bueler, A. Eichmann, R. Kauppinen, M. I. Kettunen, et al. A model for gene therapy of human hereditary lymphedema PNAS, October 23, 2001; 98(22): 12677 - 12682. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
